Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Dementia Jaqueline Raetz, M.D.. Types of Dementia Alzheimer Dementia 70% Lewy Body Dementia about 22% Vascular Dementia 17% Frontotemporal Dementia Overall.
Outcomes of thrombolysis treatment in patients with dementia and acute ischemic stroke A longitudinal cohort study from SveDem and Riksstroke, Swedish.
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Fig. 1 Urea-based Aβ-SDS–PAGE/immunoblot (A) and conventional SDS–PAGE (B) of CSF (lane 1–4,6) and synthetic Aβ-peptides 1–37, 1–38, 1–39, 1–40, 1–42 (lane.
Dement Geriatr Cogn Disord 2011;31:239– DOI: /
Fig. 1 The effects of modelling global volume for the analysis of PDD relative to controls. Atrophy in PDD shown (A) compensated for differences in head.
Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly 
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study  Wesley.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Dementia-Related Epilepsy in Vascular Dementia and Alzheimer’s Disease
Clinical and genetic analyses of familial and sporadic frontotemporal dementia patients in Southern Italy  Rosa Capozzo, Celeste Sassi, Monia B. Hammer,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease  Azadeh Karami, Helga Eyjolfsdottir, Swetha.
A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES 
Body Mass Index in Different Dementia Disorders: Results from the Swedish Dementia Quality Registry (SveDem) Dement Geriatr Cogn Disord Extra 2014;4:65-75.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Using the Disease State Fingerprint Tool for Differential Diagnosis of Frontotemporal Dementia and Alzheimer's Disease Dement Geriatr Cogn Disord Extra.
Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample  Marie Eckerström,
The differential diagnosis of amnestic mild cognitive impairment and Alzheimer's disease dementia by hippocampal volume measurement with MR in a chinese.
Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study - DOI: / Fig. 1.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire  Roos J.
Christine Bredfeldt, Kristen Rice, Lisa Alecxih 
SMARTPHONE TECHNOLOGY TO MEASURE HEALTH CHARACTERISTICS IN OFFSPRING OF PATIENTS WITH DEMENTIA: THE IVITALITY PROOF-OF- PRINCIPLE STUDY  Liselotte Wijsman,
Volume 3, Issue 2, Pages (June 2017)
Volume 5, Pages (December 2016)
Fig. 11. Algorithm for differential diagnosis of cognitive impaired subjects by employing structural imaging. AD = Alzheimer's disease, BG = basal ganglia,
Application of Resource Utilization in Dementia (RUD) instrument in a global setting  Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS  Teemu Paajanen, Shadi Mahdiani, Marie.
Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline  Sander C.J.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Ben Sherwood, Andrew Xiao-Hua Zhou, Sandra Weintraub, Lan Wang 
פסיכוגריאטריה ד''ר שורצמן בי''ח פלימן.
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin  Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja,
Clinical Spectrum, Risk Factors, and Behavioral Abnormalities among Dementia Subtypes in a North Indian Population: A Hospital-Based Study Dement Geriatr.
Early Dementia Distinguishing AD From MCI
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment  Shangran.
Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.
Ara S. Khachaturian, David P
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Application of Resource Utilization in Dementia (RUD) instrument in a global setting  Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:
The validity of the Memory Alteration Test and the Test Your Memory test for community- based identification of amnestic mild cognitive impairment  Seline.
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease  Antoine Leuzy, Elena Rodriguez-Vieitez,
LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE  Charissa Poon, Kullervo Hynynen  Alzheimer's.
Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective  Matthew Baumgart, Heather M. Snyder,
Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision.
Introduction: Evolution of military and veterans brain health research
Supportive care for patients with renal disease: Time for action
The incremental diagnostic value of 18F-florbetapir imaging in naturalistic patients with cognitive impairment: The India-FBP study  Marina Boccardi,
Linus Jönsson, Pei-Jung Lin, Ara S. Khachaturian 
Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease  Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients  Eric R. Siemers, Karen L. Sundell, Christopher Carlson, Michael Case,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS  Betty M. Tijms, Mara ten Kate, Sander C.J.
Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:
Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years  Kevin A. Matthews,
BRAIN AMYLOIDOSIS AND COGNITIVE DECLINE IN MCI: 12-MONTH FOLLOW-UP
Increased risk for dementia both before and after stroke: A population-based study in women followed over 44 years  Xinxin Guo, Svante Östling, Silke.
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER.
Susan D. Rountree, Alireza Atri, Oscar L. Lopez, Rachelle S. Doody 
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
Presentation transcript:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Dental care utilization in patients with different types of dementia: A longitudinal nationwide study of 58,037 individuals  Seyed-Mohammad Fereshtehnejad, Sara Garcia-Ptacek, Dorota Religa, Jacob Holmer, Kåre Buhlin, Maria Eriksdotter, Gunilla Sandborgh-Englund  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  DOI: 10.1016/j.jalz.2017.05.004 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Panel data to show yearly changes in dental care utilization (total and separated by procedure type) before and after dementia diagnosis (shown by the dotted line) in patients registered in SveDem with available follow-up data for at least 1 year before and 1 year after diagnostic date (n = 41,870). Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.05.004) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Panel data to show yearly changes in dental care utilization before and after dementia diagnosis (shown by the dotted line) in patients registered in SveDem with (A) different types of dementia (Greenhouse-Geisser adjusted P-value of <.001 for time × group interaction); (B) different severity of cognitive impairment at the time of registration (Greenhouse-Geisser P-value of <.001 for time × group interaction adjusted for the baseline difference on the 3rd year before dementia diagnosis); and (C) different severity of cognitive decline (Greenhouse-Geisser P-value of <.001 for time × group interaction adjusted for the baseline difference on the 3rd year before dementia diagnosis). Abbreviations: AD, Alzheimer's disease; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; MMSE, Mini–Mental State Examination; PDD, Parkinson's disease with dementia. Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.05.004) Copyright © 2017 The Authors Terms and Conditions